BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RMI2, MGC24665, 116028, C16orf75, ENSG00000175643 AND Diagnosis
3 results:

  • 1. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
    Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
    Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
    Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
    Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
    Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
    Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.